Larimar Therapeutics (LRMR) Invested Capital: 2013-2020
Historic Invested Capital for Larimar Therapeutics (LRMR) over the last 7 years, with Sep 2020 value amounting to $102.6 million.
- Larimar Therapeutics' Invested Capital rose 71.41% to $102.6 million in Q3 2020 from the same period last year, while for Sep 2020 it was $102.6 million, marking a year-over-year increase of 71.41%. This contributed to the annual value of -$694,000 for FY2019, which is 100.74% down from last year.
- According to the latest figures from Q3 2020, Larimar Therapeutics' Invested Capital is $102.6 million, which was down 8.80% from $112.5 million recorded in Q2 2020.
- In the past 5 years, Larimar Therapeutics' Invested Capital ranged from a high of $154.4 million in Q1 2016 and a low of -$694,000 during Q4 2019.
- Moreover, its 3-year median value for Invested Capital was $72.1 million (2019), whereas its average is $72.2 million.
- As far as peak fluctuations go, Larimar Therapeutics' Invested Capital slumped by 100.74% in 2019, and later skyrocketed by 71.41% in 2020.
- Over the past 5 years, Larimar Therapeutics' Invested Capital (Quarterly) stood at $121.7 million in 2016, then crashed by 35.74% to $78.2 million in 2017, then rose by 19.25% to $93.3 million in 2018, then crashed by 100.74% to -$694,000 in 2019, then skyrocketed by 71.41% to $102.6 million in 2020.
- Its Invested Capital stands at $102.6 million for Q3 2020, versus $112.5 million for Q2 2020 and $50.7 million for Q1 2020.